Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
Investigative Ophthalmology & Visual Science|October 17, 2025
Measuring Rod- and Cone-Photoreceptor-Specific Vision in Inherited Retinal Diseases Using a Commercial PerimeterVivian Wu, Alejandro J Roman, Emma L Galsterer, et al.
Investigative Ophthalmology & Visual Science|July 7, 2009
CERKL mutations cause an autosomal recessive cone-rod dystrophy with inner retinopathyTomas S Aleman, Nagasamy Soumittra, Artur V Cideciyan, et al.
Human Molecular Genetics|May 9, 2008
Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanismSamuel G Jacobson, Artur V Cideciyan, Tomas S Aleman, et al.
Gynecologic Oncology|August 25, 2001
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancerM L Donato, D M Gershenson, J T Wharton, et al.
Retina (Philadelphia, Pa.)|January 12, 2018
FREQUENT SUBCLINICAL MACULAR CHANGES IN COMBINED BRAF/MEK INHIBITION WITH HIGH-DOSE HYDROXYCHLOROQUINE AS TREATMENT FOR ADVANCED METASTATIC BRAF MUTANT MELANOMA: Preliminary Results From a Phase I/II Clinical Treatment TrialAkosua A Nti, Leona W Serrano, Harpal S Sandhu, et al.
Investigative Ophthalmology & Visual Science|July 16, 2011
Human CRB1-associated retinal degeneration: comparison with the rd8 Crb1-mutant mouse modelTomas S Aleman, Artur V Cideciyan, Geoffrey K Aguirre, et al.
International Journal of Molecular Sciences|October 16, 2024
Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene TherapyArtur V Cideciyan, Alejandro J Roman, Raymond L Warner, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2008
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kineticsArtur V Cideciyan, Tomas S Aleman, Sanford L Boye, et al.
Lancet (London, England)|September 7, 2024
Safety and efficacy of ATSN-101 in patients with Leber congenital amaurosis caused by biallelic mutations in GUCY2D: a phase 1/2, multicentre, open-label, unilateral dose escalation studyPaul Yang, Laura P Pardon, Allen C Ho, et al.
Human Gene Therapy|September 1, 2006
Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosisSamuel G Jacobson, Sanford L Boye, Tomas S Aleman, et al.
Pageof 20